Myelodysplastic syndromes (MDS) with a deletion 5q display a specific immunophenotypic profile

被引：0
|
作者：
Oelschlaegel, U. [1 ]
Westers, T. M. [2 ]
Mohr, B. [1 ]
Parmentier, S. [1 ]
Sockel, K. [1 ]
Bornhaeuser, M. [1 ]
Van de Loosdrecht, A. A. [2 ]
Platzbecker, U. [1 ]
机构：
[1] Univ Hosp Dresden, Med Clin & Policlin 1, Dresden, Germany
[2] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70106-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-057
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [1] Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring
    Oelschlaegel, Uta
    Westers, Theresia M.
    Mohr, Brigitte
    Kramer, Michael
    Parmentier, Stefani
    Sockel, Katja
    Thiede, Christian
    Bornhaeuser, Martin
    Ehninger, Gerhard
    van de Loosdrecht, Arjan A.
    Platzbecker, Uwe
    HAEMATOLOGICA, 2015, 100 (03) : E93 - E96
  • [2] Atypical deletion of 5q in myelodysplastic syndromes (MDS)
    Zemanova, Z.
    Brezinova, J.
    Svobodova, K.
    Lhotska, H.
    Izakova, S.
    Lizcova, L.
    Vesela, D.
    Ransdorfova, S.
    Mendlikova, I.
    Michalova, K.
    Cermak, J.
    Jonasova, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 510 - 510
  • [3] MDS with deletion 5q - a distinct subtype of myelodysplastic syndromes
    Wilk, Christian Matthias
    Goede, Jeroen Simon
    THERAPEUTISCHE UMSCHAU, 2022, 79 (02) : 87 - 91
  • [4] Myelodysplastic syndromes 5q deletion in childhood
    Iriani, A.
    LEUKEMIA RESEARCH, 2013, 37 : S93 - S93
  • [5] Molecular pathogenesis of myelodysplastic syndromes with deletion 5q
    Lee, Jung-hoon
    List, Alan
    Sallman, David A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (03) : 203 - 209
  • [6] Variability in the extent of del(5q) in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Izakova, Silvia
    Sarova, Iveta
    Lizcova, Libuse
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    Michalova, Kyra
    MOLECULAR CYTOGENETICS, 2019, 12
  • [7] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Mahmoud R. Gaballa
    Emmanuel C. Besa
    Annals of Hematology, 2014, 93 : 723 - 733
  • [8] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Gaballa, Mahmoud R.
    Besa, Emmanuel C.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 723 - 733
  • [9] TP53 Gene allelic State in Myelodysplastic Syndromes (MDS) with Isolated 5q Deletion
    Montoro, Julia
    Palomo, Laura
    Haferlach, Claudia
    Acha, Pamela
    Chan, Onyee
    Navarro Garces, Victor
    Kubota, Yasuo
    Schulz, Felicitas
    Meggendorfer, Manja
    Briski, Robert
    Al Ali, Najla H.
    Xicoy, Blanca
    Lopez, Felix
    Vidal, Pablo
    Bosch, Francesc
    Gonzalez, Teresa
    Eder, Lea Naomi
    Jerez, Andres
    Tien, Hwei-Fang
    Santini, Valeria
    Bernal Del Castillo, Teresa
    Such, Esperanza
    Wang, Yu-Hung
    Kubasch, Anne Sophie
    Platzbecker, Uwe
    Haase, Detlef
    Diez-Campelo, Maria
    Della Porta, Matteo Giovanni
    Garcia-Manero, Guillermo
    Wiseman, Daniel H.
    Germing, Ulrich
    Maciejewski, Jaroslaw P.
    Komrokji, Rami S.
    Sole, Francesc
    Haferlach, Torsten
    Valcarcel, David
    BLOOD, 2023, 142
  • [10] Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q
    Nimer, Stephen D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (16) : 2576 - 2582
12345